Bob is a seasoned finance executive and entrepreneur with deep experience in building, financing, operating, and achieving exits for start-up ventures. Over the past 20 years, he has held senior management and advisory roles at a variety of public and private healthcare, technology and life science companies, gaining significant proficiency in capital formation, corporate finance, operations, M&A, and business development. During his career, he has directed or facilitated financing and M&A transactions totaling over $1 billion. Prior to joining Voxox, Bob served in senior leadership roles at several high growth companies including StemImmune, Inc., WorkWell Prevention and Care, Ambit Biosciences (commercial unit acquired by DiscoverX), NovaCardia (clinical stage drug assets acquired by Merck), Ancile Pharmaceuticals, Molecular Biosystems, and Sequana Therapeutics (acquired by Arris Pharmaceutical). Mr. Giargiari holds a Bachelor of Arts degree in sociology and economics from Harvard and a Masters in Business Administration from the Anderson School at UCLA.